je.st
news
Amgen, Cytokinetics Heart Failure Drug Succeeds In Mid-Stage Study
2015-10-28 08:39:05| Biotech - Topix.net
Amgen Inc and Cytokinetics Inc said on Tuesday their experimental drug for chronic heart failure showed significant improvement in cardiac function in the second part of a mid-stage study. The 448 patients in the trial were given an oral formulation of the drug omecamtiv mecarbil for 20 weeks and observed for 24 weeks, the companies said in a joint statement.
Tags: study
heart
drug
failure
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||